ProShare Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,484
| Closed | -$78K | – | 2233 |
|
|
2022
Q1 | $78K | Sell |
11,484
-2,933
| -20% | -$19.9K | ﹤0.01% | 2072 |
|
|
2021
Q4 | $120K | Sell |
14,417
-753
| -5% | -$6.27K | ﹤0.01% | 2166 |
|
|
2021
Q3 | $113K | Sell |
15,170
-2,584
| -15% | -$19.2K | ﹤0.01% | 1900 |
|
|
2021
Q2 | $121K | Buy |
17,754
+6,882
| +63% | +$46.9K | ﹤0.01% | 2266 |
|
|
2021
Q1 | $112K | Buy |
+10,872
| New | +$112K | ﹤0.01% | 2152 |
|
|
2018
Q4 | – | Sell |
-15,233
| Closed | -$99K | – | 1738 |
|
|
2018
Q3 | $99K | Sell |
15,233
-496
| -3% | -$3.22K | ﹤0.01% | 1681 |
|
|
2018
Q2 | $120K | Sell |
15,729
-1,030
| -6% | -$7.86K | ﹤0.01% | 1689 |
|
|
2018
Q1 | $375K | Sell |
16,759
-2,762
| -14% | -$61.8K | ﹤0.01% | 1218 |
|
|
2017
Q4 | $249K | Buy |
+19,521
| New | +$249K | ﹤0.01% | 1518 |
|